Welcome to the e-CCO Library!

P256: Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Laterza*1, M. E. Ainora1, M. Garcovich1, A. Poscia2, A. Lupascu3, L. Riccardi1, F. Scaldaferri1, A. Armuzzi4, A. Gasbarrini1, G. L. Rapaccini4, M. Pompili1, M. A. Zocco1

Created: Friday, 22 February 2019, 9:41 AM
P256: Correlation of fecal calprotectin levels with endoscopic severity evaluated with balloon-assisted endoscopy in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Matsuoka K.*1, Iwamoto F.1,2, Kimura M.1, Takenaka K.1, Fujii T.1, Nagahori M.1, Enomoto N.2, Ohtsuka K.1, Watanabe M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P256: High disease burden of CROHN'S DISEASE (CD) in a Latin American IBD reference center
Year: 2021
Source: ECCO'21 Virtual
Authors: Sambuelli, A.(1);Gil , A.(1);Negreira , S.(1);Tirado , P.(1);Huernos, S.(1);Goncalves , S.(1);Lakatos , P.(2,3);
Created: Wednesday, 2 June 2021, 4:12 PM
P256: Risk of relapse according to endoscopic score of mucosal healing (mayo score 0 vs. 1): Clinical evaluation is still necessary
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Ramos1*, R. De La Barreda1, M. Carrillo-Palau1, I. Alonso-Abreu1, N. Hernández-Álvarez1, G. Hernández1, A. Hernandez Camba1, L. Martínez-Blanco2, A. Jiménez3, E. Quintero Carrión1,4

Created: Thursday, 21 February 2019, 9:14 AM
P256: The practical use of an eHealth platform for inflammatory bowel disease patients: the validation of the IBD Tool web-based tele-monitoring system
Year: 2022
Source: ECCO'22
Authors: Giuffrida, E.(1,2);Mangia, M.(1,3);Figini, V.(4);Carli, E.(1);Colombo, A.(1);Mendolaro, M.(1);Lavagna, A.(1);Lia, C.(5);Bonina, M.(5);Martínez De Carnero, F.(5);Morello, E.(1);Cosimato, M.(1);Rocca, R.(1);Pagna, G.(4,5);Daperno, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P256: Urinary lithogenic profile and gut and urinary microbiota in patients with inflammatory bowel diseases
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mignini, I.(1)*;Masucci, L.(2);De Maio, F.(2);Laterza, L.(1);Scaldaferri, F.(1);Settanni, C.R.(1);Napolitano, D.(1);Baroni, S.(3);Garcovich, M.(1);Riccardi, L.(1);Gasbarrini, A.(1);Ferraro, P.M.(4);Papa, A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P257 Prognostic value of bowel ultrasonography for the management of Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C.J. Suarez Ferrer, J. Poza Cordon, O. Crivillen Anguita, E. Martin Arranz, J.L. Rueda Garcia, M. Sanchez Azofra, L. Garcia Ramirez, J. Noci Belda, M.D. Martin Arranz

Created: Thursday, 30 January 2020, 10:12 AM
P257: Assessment of the nutritional status of pediatric Inflammatory Bowel Disease patients according to disease activity.
Year: 2021
Source: ECCO'21 Virtual
Authors: Palomino Pérez, L.M.(1);Velasco Rodríguez-Belvis , M.(1);Cañedo Villaroya, E.(1);Vazquez Gómez, J.A.(1);Muñoz Codoceo, R.A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P257: Evaluation of serum ICAM-1 and VCAM-1 as biomarkers for disease progression in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bar Orr I.*1, Martin de Carpi J.2, Amil Dias J.3, Levine A.4, Nuti F.5, Lionetti P.6, Escher J.7

Created: Wednesday, 20 February 2019, 10:36 AM
P257: Is colorectal screening in IBD fit for purpose?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Saeidinejad, M.(1);Dawson, H.E.(2)*;Newbury, C.M.(2);Searle, H.(2);Gordon, J.N.(2);
Created: Friday, 14 July 2023, 11:05 AM
P257: Monitoring of calprotectin levels in IBD patients with point-of-care test CalproSmart™
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Ulanova*1, E. Moerk1

Created: Friday, 22 February 2019, 9:41 AM
P257: Relationship between ocular vascular changes, malondialdehyde and vascular endothelial growth factor levels in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Sengul Samanci1, S. Poturoglu2, C. Samanci3, A. E. Duman*2, A. Ciftcibasi Ormeci2

Created: Friday, 22 February 2019, 9:49 AM
P257: Surgical and hospital admission in adults newly diagnosed with inflammatory bowel disease (IBD) in the biological era in Spain: Results of the nationwide EpidemIBD study of GETECCU
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Chaparro1,2,3,4*, J.L. Cabriada5, M.J. Casanova1,2,4, D. Ceballos6, M. Esteve4,7, H. Fernández8, M. Barreiro-de Acosta9, V. García-Sánchez10,11, D. Ginard12, F. Gomollón4,13,14, R. Llorente Poyatos15, P. Nos4,16, S. Riestra17, M. Rivero18, P. Robledo19, C. Rodríguez Gutiérrez20, B. Sicilia21, E. Torrella22, E. García Esquinas23,24,25, J.P. Gisbert1,2,3,4, on behalf of the EpidemIBD group

Created: Thursday, 21 February 2019, 9:14 AM
P257: The clinical decision support tool has low performance in predicting outcome to ustekinumab in Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Alsoud, D.(1);Sabino, J.(1,2);Ferrante, M.(1,2);Verstockt , B.(1,2);Vermeire, S.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P258 Managing an ever-increasing inflammatory bowel disease helpline service
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Scott1, L. Gower1, N. Roads2, W. Lewis3

Created: Thursday, 30 January 2020, 10:12 AM
P258: 3D printed models in fistulising perianal Crohn's as a clinical tool boost education with patients and trainees
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Sahnan1*, S.O. Adegbola1, P.J. Tozer1, A. Gupta2, J. Warusavitarne1, O.D. Faiz1, A.L. Hart3, R.K. Phillips1, P.F. Lung2

Created: Thursday, 21 February 2019, 9:14 AM
P258: Abdominal pain and its relationship with clinical outcomes, biomarker levels, and health-related quality of life in patients with moderate to severe ulcerative colitis: data from U-ACHIEVE, a Phase 2b study of upadacitinib
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Danese*1, E. Louis2, E. V. Loftus Jr3, F. Cataldi4, H. Guay4, W-J. Lee4, S. Ghosh5

Created: Friday, 22 February 2019, 9:41 AM
P258: Disease course and operative risk after diagnosis of ileal penetrating Crohn's disease: a cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bossuyt P.*1,2, Debeuckelaere C.1, Ferrante M.1, De Buck van Overstraeten A.3, Billiet T.1, Vanbeckevoort D.4, Wolthuis A.3, D'Hoore A.3, Van Assche G.1, Vermeire S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P258: Impact of inflammatory bowel diseases on the phenotype and severity of primary sclerosing cholangitis - a systematic review with meta-analysis
Year: 2022
Source: ECCO'22
Authors: Attauabi, M.(1,2,3);Wewer, M.D.(1,3);Bendtsen, F.(1,3);Seidelin, J.B.(2);Burisch, J.(1,3);
Created: Friday, 11 February 2022, 3:52 PM
P258: Prospective follow-up of serologic responses in ulcerative colitis patients with an ileal pouch reveals they are stable over time and do not correlate with the clinical phenotype of the pouch
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

I. Goren*1, L. Yahav2, H. Tulchinsky3, 4, I. Dotan4, 5

Created: Friday, 22 February 2019, 9:49 AM